Radical surgery for osteogenic sarcoma resulted in a five-year survival rate of 25.5%, with significantly better survival in patients aged 15 years or younger (p<0.05).
Observational (n=130)
In this cohort of osteogenic sarcoma patients, the five-year survival rate after radical surgery was 25.5%, with age ≤15 years being a significant prognostic factor.
One hundred and thirty patients with osteogenic sarcoma were studied clinically, roentgenographically, and pathologically. Prognosis by each of ten factors was analyzed with the Wilcoxon test. The test yielded p smaller than 0.05 in a comparison between the survival curves of patients fifteen years old or younger and that of patients over fifteen, but other comparisons did not yield p smaller than 0.05. The actual five-year survival rate was 25.5 per cent (twenty-six of 102 patients who had radical surgery). Our therapeutic regimen for osteogenic sarcoma at the present time consists of regional perfusion, amputation, bronchial artery infusion, and systemic administration of anticancer agents.
Ohno et al. (Tue,) conducted a observational in Osteogenic sarcoma (n=130). Radical surgery was evaluated on Five-year survival rate. Radical surgery for osteogenic sarcoma resulted in a five-year survival rate of 25.5%, with significantly better survival in patients aged 15 years or younger (p<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: